WALTHAM, Mass., Feb. 19, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2015 on Friday, February 26, 2016. With the recent announcement that Alere and Abbott have entered into a definitive merger agreement, Alere will no longer hold conference calls for quarterly earnings pending closing of the transaction.
About Alere Alere believes that when diagnosing and monitoring health conditions, Knowing now matters.™ Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.
SOURCE Alere Inc.